S H Kelkar & Company Ltd
S H Kelkar and Company Limited is engaged in manufacture, supply and exports of fragrances and aroma ingredients[1] It is the largest domestic fragrance producer in India and the only company of Indian origin to file patents in the field of Fragrance & Novel aroma molecules.
- Market Cap ₹ 3,685 Cr.
- Current Price ₹ 267
- High / Low ₹ 336 / 136
- Stock P/E 48.4
- Book Value ₹ 54.8
- Dividend Yield 0.28 %
- ROCE 16.4 %
- ROE 13.5 %
- Face Value ₹ 10.0
Pros
- Company has been maintaining a healthy dividend payout of 29.5%
Cons
- Stock is trading at 4.87 times its book value
- Promoter holding has decreased over last quarter: -3.12%
- The company has delivered a poor sales growth of 6.27% over past five years.
- Company has a low return on equity of 10.5% over last 3 years.
- Working capital days have increased from 70.5 days to 99.9 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE Allcap BSE Commodities BSE SmallCap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
341 | 399 | 471 | 559 | 615 | 682 | 694 | 719 | 761 | 807 | 880 | 941 | 1,040 | |
276 | 317 | 405 | 466 | 514 | 579 | 629 | 646 | 661 | 722 | 754 | 806 | 920 | |
Operating Profit | 65 | 81 | 66 | 93 | 101 | 103 | 65 | 73 | 100 | 85 | 125 | 134 | 119 |
OPM % | 19% | 20% | 14% | 17% | 16% | 15% | 9% | 10% | 13% | 11% | 14% | 14% | 11% |
2 | 3 | 32 | 24 | 11 | 14 | 19 | 10 | 34 | 13 | -16 | 21 | -102 | |
Interest | 19 | 15 | 13 | 14 | 3 | 3 | 7 | 12 | 6 | 4 | 5 | 7 | 10 |
Depreciation | 12 | 13 | 15 | 13 | 7 | 11 | 15 | 28 | 28 | 28 | 27 | 26 | 25 |
Profit before tax | 36 | 57 | 70 | 89 | 103 | 103 | 62 | 43 | 100 | 66 | 77 | 123 | -18 |
Tax % | 41% | 23% | 12% | 26% | 28% | 33% | 28% | 26% | 20% | 36% | 32% | 23% | |
22 | 44 | 62 | 66 | 74 | 69 | 45 | 32 | 80 | 42 | 52 | 94 | -43 | |
EPS in Rs | 1,792.19 | 3,316.70 | 4.66 | 4.54 | 5.14 | 4.77 | 3.11 | 2.26 | 5.64 | 3.07 | 3.77 | 6.81 | -3.10 |
Dividend Payout % | 37% | 34% | 23% | 33% | 34% | 37% | 0% | 42% | 31% | 24% | 53% | 11% |
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 6% |
3 Years: | 7% |
TTM: | 14% |
Compounded Profit Growth | |
---|---|
10 Years: | 8% |
5 Years: | 16% |
3 Years: | 6% |
TTM: | -13% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 18% |
3 Years: | 19% |
1 Year: | 74% |
Return on Equity | |
---|---|
10 Years: | 11% |
5 Years: | 10% |
3 Years: | 11% |
Last Year: | 13% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 12 | 13 | 132 | 145 | 145 | 145 | 145 | 141 | 141 | 138 | 138 | 138 |
Reserves | 292 | 256 | 168 | 401 | 474 | 483 | 452 | 427 | 494 | 463 | 504 | 620 |
94 | 119 | 154 | 0 | 1 | 19 | 87 | 76 | 67 | 47 | 95 | 83 | |
79 | 107 | 100 | 114 | 140 | 207 | 207 | 298 | 329 | 370 | 347 | 359 | |
Total Liabilities | 477 | 495 | 555 | 660 | 759 | 854 | 891 | 943 | 1,031 | 1,018 | 1,086 | 1,201 |
98 | 104 | 94 | 93 | 114 | 154 | 201 | 254 | 222 | 224 | 202 | 186 | |
CWIP | 26 | 0 | 0 | 0 | 5 | 18 | 24 | 13 | 17 | 3 | 8 | 6 |
Investments | 113 | 98 | 99 | 167 | 220 | 269 | 269 | 253 | 321 | 322 | 311 | 343 |
241 | 293 | 361 | 400 | 421 | 412 | 397 | 422 | 472 | 470 | 565 | 666 | |
Total Assets | 477 | 495 | 555 | 660 | 759 | 854 | 891 | 943 | 1,031 | 1,018 | 1,086 | 1,201 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
90 | 10 | 21 | 45 | 67 | 118 | 105 | 187 | 84 | 84 | -11 | 30 | |
-14 | -30 | 26 | -57 | -92 | -88 | -87 | -32 | -65 | 10 | -24 | -20 | |
-66 | 10 | 0 | 3 | -3 | -49 | -13 | -124 | -24 | -116 | 33 | 4 | |
Net Cash Flow | 10 | -9 | 47 | -9 | -28 | -19 | 5 | 31 | -5 | -21 | -3 | 14 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 76 | 76 | 59 | 75 | 82 | 100 | 66 | 74 | 96 | 73 | 59 | 66 |
Inventory Days | 218 | 273 | 244 | 217 | 198 | 147 | 164 | 147 | 136 | 185 | 239 | 269 |
Days Payable | 96 | 113 | 65 | 94 | 71 | 131 | 127 | 199 | 211 | 234 | 193 | 192 |
Cash Conversion Cycle | 198 | 236 | 238 | 198 | 209 | 117 | 103 | 23 | 21 | 25 | 104 | 143 |
Working Capital Days | 154 | 133 | 142 | 151 | 160 | 109 | 98 | 33 | 49 | 35 | 76 | 100 |
ROCE % | 13% | 19% | 17% | 21% | 18% | 17% | 10% | 8% | 16% | 10% | 15% | 16% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
18 Nov - Audio recording of investor conference call available.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
15 Nov - Participation in Kotak Midcap Conference 2024 scheduled on Thursday, November 21, 2024
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Nov - Newspaper Publication in respect of Unaudited Financial Results for the quarter and half year ended September 30, 2024
- Submission Of Earnings Presentation And Press Release In Respect Of Unaudited (Standalone & Consolidated) Financial Results For The Quarter And Half Year Ended September 30, 2024 14 Nov
-
Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2024
14 Nov - Board approved unaudited financial results for Q2 FY2024.
Annual reports
Concalls
-
Nov 2024TranscriptNotesPPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023TranscriptPPT
-
Feb 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Oct 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jul 2021TranscriptNotesPPT
-
Jun 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Dec 2020Transcript PPT
-
Nov 2020TranscriptNotesPPT
-
Sep 2020TranscriptPPT
-
Sep 2020Transcript PPT
-
Jul 2020TranscriptPPT
-
May 2020TranscriptNotesPPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Sep 2019Transcript PPT
-
Jun 2019TranscriptPPT
-
May 2019TranscriptNotesPPT
-
Feb 2019Transcript PPT
-
Dec 2018Transcript PPT
-
Sep 2018Transcript PPT
-
Aug 2018TranscriptNotesPPT
-
Jun 2018Transcript PPT
-
Feb 2018TranscriptPPT
-
Jan 2018Transcript PPT
-
Nov 2017TranscriptPPT
-
Oct 2017TranscriptNotesPPT
-
Sep 2017Transcript PPT
-
Jun 2017TranscriptPPT
-
Mar 2017Transcript PPT
-
Nov 2016Transcript PPT
-
Sep 2016TranscriptPPT
-
Aug 2016TranscriptNotesPPT
-
Jun 2016Transcript PPT
-
Mar 2016TranscriptPPT
Product Portfolio
Fragrances - Personal care, Hair care, Skin care & cosmetics, fabric care, House products, etc.
Flavors - Food applications format, High-performance formats, etc...
Services - Biotechnology research service, Cosmetic research services, custom synthesis service. [1]
Co. offers products under the SHK, Cobra, Auris, Wheel, Three Birds and Keva brands. In FY23, the Fragrance segment remained the primary revenue contributor with ~87% share[2].The company has about 9700+SKUs.[3]